Nifty

:

20855.10

Sensex

:

69296.14

168.30 (0.81%)
431.02 (0.63%)

Login

Nifty
Sensex

:
:

20855.10
69296.14

168.30 (0.81%)
431.02 (0.63%)

Ajanta Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 532331 | NSE: AJANTPHARM

Watchlist

NSE BSE

1966.85

05-Dec-2023

Open
High
Low
Previous Close

1959.90
1981.65
1920.10
1959.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

101775
1986.15
1998.70
1131.70

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

24,775.79
37.36
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

24,513.93
0.36%
7.08

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.97
12.73
9.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.82
6.70
-4.74

PAT CAGR (%)

10 Years
5 Years
3 Years

9.66
8.73
-3.48

P:E (Median)

8 Years
5 Years
3 Years

25.70
25.14
25.66

P:BV (Average)

8 Years
5 Years
3 Years

6.17
4.88
5.30

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.45
16.46
17.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 945.18 837.23 12.89% 1,014.58 850.29 19.32% 848.86 765.63 10.87% 874.89 808.58 8.20%
Expenses 671.53 676.50 -0.73% 737.68 663.98 11.10% 704.33 578.48 21.76% 715.48 570.71 25.37%
EBITDA 273.65 160.73 70.25% 276.90 186.31 48.62% 144.53 187.15 -22.77% 159.41 237.87 -32.98%
EBIDTM 28.95% 19.20% 27.29% 21.91% 17.03% 24.44% 18.22% 29.42%
Other Income 52.16 78.37 -33.44% 31.46 35.42 -11.18% 36.75 28.42 29.31% 30.51 27.90 9.35%
Interest 2.27 0.71 219.72% 0.75 0.63 19.05% 1.21 7.18 -83.15% 2.68 0.70 282.86%
Depreciation 33.04 31.80 3.90% 32.24 30.75 4.85% 32.11 30.09 6.71% 32.29 30.71 5.14%
PBT 290.50 206.59 40.62% 275.37 190.35 44.67% 147.96 178.30 -17.02% 154.95 234.36 -33.88%
Tax 78.14 39.41 98.27% 63.33 39.98 58.40% 30.75 43.46 -29.25% 30.99 39.65 -21.84%
PAT 212.36 167.18 27.02% 212.04 150.37 41.01% 117.21 134.84 -13.07% 123.96 194.71 -36.34%
PATM 22.47% 19.97% 20.90% 17.68% 13.81% 17.61% 14.17% 24.08%
EPS 16.87 13.28 27.03% 16.84 11.94 41.04% 9.31 10.71 -13.07% 9.85 15.47 -36.33%

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 1,028.44 938.10 9.63% 1,021.04 950.93 7.37% 881.84 870.29 1.33% 971.77 837.91 15.98%
Expenses 737.78 741.76 -0.54% 749.72 729.17 2.82% 732.47 663.60 10.38% 802.22 598.33 34.08%
EBITDA 290.66 196.34 48.04% 271.32 221.76 22.35% 149.37 206.69 -27.73% 169.55 239.58 -29.23%
EBIDTM 28.26% 20.93% 26.57% 23.32% 16.94% 23.75% 17.45% 28.59%
Other Income 21.33 40.35 -47.14% 31.75 32.76 -3.08% 36.83 29.48 24.93% 34.93 24.03 45.36%
Interest 2.34 0.99 136.36% 0.85 0.88 -3.41% 1.13 7.34 -84.60% 2.84 0.95 198.95%
Depreciation 33.71 32.70 3.09% 33.18 31.78 4.41% 33.02 31.16 5.97% 33.30 31.72 4.98%
PBT 275.94 203.00 35.93% 269.04 221.86 21.27% 152.05 197.67 -23.08% 168.34 230.94 -27.11%
Tax 80.64 46.40 73.79% 60.92 47.24 28.96% 29.80 46.46 -35.86% 33.83 39.16 -13.61%
PAT 195.30 156.60 24.71% 208.12 174.62 19.18% 122.25 151.21 -19.15% 134.51 191.78 -29.86%
PATM 18.99% 16.69% 20.38% 18.36% 13.86% 17.37% 13.84% 22.89%
EPS 15.46 12.18 26.93% 16.47 13.58 21.28% 9.68 11.74 -17.55% 10.46 14.70 -28.84%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 3,683.51 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62 1,825.35 1,804.33 1,558.21 1,356.20 1,109.92 Net Sales Growth 12.93% 8.62% 15.52% 23.77% 23.91% -2.89% 1.16% 15.80% 14.90% 22.19% Cost Of Goods Sold 1,034.28 824.32 679.10 600.59 546.67 304.80 311.26 348.99 318.31 306.55 285.50 Gross Profit 2,649.23 2,586.95 2,461.54 2,118.00 1,649.75 1,467.82 1,514.09 1,455.34 1,239.90 1,049.65 824.42 GP Margin 71.92% 75.84% 78.38% 77.91% 75.11% 82.81% 82.95% 80.66% 79.57% 77.40% 74.28% Total Expenditure 2,829.02 2,711.99 2,249.75 1,801.68 1,663.64 1,291.41 1,278.54 1,169.91 1,035.65 883.64 764.39 Power & Fuel Cost - 65.53 54.09 43.42 38.56 33.77 27.00 18.36 15.15 12.58 10.86 % Of Sales - 1.92% 1.72% 1.60% 1.76% 1.91% 1.48% 1.02% 0.97% 0.93% 0.98% Employee Cost - 720.41 585.87 498.11 437.82 389.37 342.89 269.78 235.03 186.34 147.25 % Of Sales - 21.12% 18.65% 18.32% 19.93% 21.97% 18.78% 14.95% 15.08% 13.74% 13.27% Manufacturing Exp. - 320.69 273.91 225.39 203.80 176.40 212.44 188.68 173.18 129.58 96.80 % Of Sales - 9.40% 8.72% 8.29% 9.28% 9.95% 11.64% 10.46% 11.11% 9.55% 8.72% General & Admin Exp. - 348.78 289.42 123.71 150.92 165.95 122.50 85.96 61.61 46.98 42.84 % Of Sales - 10.22% 9.22% 4.55% 6.87% 9.36% 6.71% 4.76% 3.95% 3.46% 3.86% Selling & Distn. Exp. - 354.87 316.58 248.70 225.44 178.54 173.75 161.51 164.06 154.44 140.19 % Of Sales - 10.40% 10.08% 9.15% 10.26% 10.07% 9.52% 8.95% 10.53% 11.39% 12.63% Miscellaneous Exp. - 77.39 50.78 61.76 60.43 42.58 88.70 96.63 68.31 47.17 140.19 % Of Sales - 2.27% 1.62% 2.27% 2.75% 2.40% 4.86% 5.36% 4.38% 3.48% 3.69% EBITDA 854.49 699.28 890.89 916.91 532.78 481.21 546.81 634.42 522.56 472.56 345.53 EBITDA Margin 23.20% 20.50% 28.37% 33.73% 24.26% 27.15% 29.96% 35.16% 33.54% 34.84% 31.13% Other Income 150.88 132.75 139.73 103.57 184.20 102.15 73.01 66.95 86.87 33.70 17.72 Interest 6.91 5.23 9.12 6.90 9.10 0.41 0.24 1.24 4.19 5.01 8.22 Depreciation 129.68 126.95 120.96 111.49 91.29 69.90 57.14 59.48 42.68 49.42 41.97 PBT 868.78 699.85 900.54 902.09 616.59 513.05 562.44 640.65 562.56 451.83 313.06 Tax 203.21 141.13 180.68 226.45 171.54 121.29 134.92 140.84 140.61 138.51 92.20 Tax Rate 23.39% 20.17% 20.06% 25.10% 28.00% 23.64% 23.99% 21.98% 24.99% 31.13% 29.45% PAT 665.57 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 220.86 PAT before Minority Interest 665.57 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 220.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.07% 16.38% 22.92% 24.85% 20.08% 22.10% 23.42% 27.70% 27.08% 22.59% 19.90% PAT Growth 2.85% -22.38% 6.54% 53.16% 12.60% -8.36% -14.46% 18.45% 37.73% 38.72% EPS 52.86 44.38 57.18 53.66 35.04 31.12 33.96 39.70 33.51 24.33 17.54

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 3,903.09 3,742.64 3,340.99 2,889.69 2,587.87 2,055.37 2,125.76 1,983.26 1,733.98 1,473.56 1,208.34 Net Sales Growth 8.50% 12.02% 15.62% 11.66% 25.91% -3.31% 7.19% 14.38% 17.67% 21.95% Cost Of Goods Sold 1,018.25 869.31 677.73 514.99 537.75 295.72 317.35 322.58 317.33 290.33 283.98 Gross Profit 2,884.84 2,873.33 2,663.26 2,374.70 2,050.12 1,759.65 1,808.41 1,660.68 1,416.65 1,183.23 924.36 GP Margin 73.91% 76.77% 79.71% 82.18% 79.22% 85.61% 85.07% 83.73% 81.70% 80.30% 76.50% Total Expenditure 3,022.19 2,959.39 2,411.70 1,891.13 1,904.55 1,488.94 1,467.37 1,296.38 1,146.92 968.33 839.59 Power & Fuel Cost - 65.71 54.38 43.70 38.88 32.65 27.42 18.70 15.49 12.91 11.20 % Of Sales - 1.76% 1.63% 1.51% 1.50% 1.59% 1.29% 0.94% 0.89% 0.88% 0.93% Employee Cost - 785.14 645.78 548.25 485.59 430.71 376.47 295.42 256.64 200.58 156.97 % Of Sales - 20.98% 19.33% 18.97% 18.76% 20.96% 17.71% 14.90% 14.80% 13.61% 12.99% Manufacturing Exp. - 320.81 275.42 226.20 204.81 174.78 215.80 192.70 174.40 130.81 96.29 % Of Sales - 8.57% 8.24% 7.83% 7.91% 8.50% 10.15% 9.72% 10.06% 8.88% 7.97% General & Admin Exp. - 365.86 300.83 131.64 159.49 149.90 131.92 92.02 66.24 50.99 47.40 % Of Sales - 9.78% 9.00% 4.56% 6.16% 7.29% 6.21% 4.64% 3.82% 3.46% 3.92% Selling & Distn. Exp. - 463.94 400.29 374.73 413.70 320.99 306.30 270.92 245.92 233.96 201.57 % Of Sales - 12.40% 11.98% 12.97% 15.99% 15.62% 14.41% 13.66% 14.18% 15.88% 16.68% Miscellaneous Exp. - 88.62 57.27 51.62 64.33 84.19 92.11 104.04 70.90 48.75 201.57 % Of Sales - 2.37% 1.71% 1.79% 2.49% 4.10% 4.33% 5.25% 4.09% 3.31% 3.49% EBITDA 880.90 783.25 929.29 998.56 683.32 566.43 658.39 686.88 587.06 505.23 368.75 EBITDA Margin 22.57% 20.93% 27.81% 34.56% 26.40% 27.56% 30.97% 34.63% 33.86% 34.29% 30.52% Other Income 124.84 98.64 115.68 25.98 92.19 21.08 24.16 23.86 21.15 16.80 13.71 Interest 7.16 5.84 10.20 8.27 11.91 1.16 0.41 1.36 4.89 5.92 8.73 Depreciation 133.21 130.80 125.29 116.09 95.71 72.08 59.59 61.21 44.43 51.64 43.88 PBT 865.37 745.25 909.48 900.18 667.89 514.27 622.55 648.17 558.89 464.47 329.85 Tax 205.19 157.27 196.80 246.31 196.27 127.30 153.91 141.34 143.28 146.15 95.97 Tax Rate 23.71% 21.10% 21.64% 27.36% 29.56% 24.75% 24.72% 21.81% 25.64% 32.05% 29.10% PAT 660.18 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 233.88 PAT before Minority Interest 660.18 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 233.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.91% 15.71% 21.33% 22.63% 18.07% 18.83% 22.05% 25.56% 23.97% 21.03% 19.36% PAT Growth -2.08% -17.50% 8.99% 39.81% 20.86% -17.43% -7.54% 21.95% 34.13% 32.49% EPS 52.44 46.70 56.61 51.94 37.15 30.74 37.22 40.26 33.01 24.61 18.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 3,246.45 3,169.18 2,884.98 2,461.30 2,142.08 1,931.50 1,503.94 1,131.70 786.33 536.32 Share Capital 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 17.67 Total Reserves 3,220.84 3,151.71 2,867.04 2,443.29 2,123.44 1,912.18 1,486.25 1,114.01 768.22 518.08 Non-Current Liabilities 272.90 338.33 321.18 252.27 193.38 60.16 32.36 40.44 54.69 79.59 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.73 22.32 40.51 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.09 9.95 10.77 Long Term Provisions 146.55 216.04 208.12 155.01 134.15 13.16 4.89 2.59 4.76 2.83 Current Liabilities 907.84 469.70 706.28 614.30 427.47 300.19 212.24 241.55 244.83 263.96 Trade Payables 353.02 274.37 317.20 302.77 185.53 211.47 145.31 145.04 108.12 110.90 Other Current Liabilities 529.32 176.59 152.32 153.28 113.56 68.01 46.09 50.68 54.51 49.81 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.47 17.90 60.54 Short Term Provisions 25.50 18.74 236.76 158.25 128.38 20.71 20.84 11.36 64.30 42.71 Total Liabilities 4,427.19 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85 879.87 Net Block 1,484.01 1,483.91 1,518.79 1,449.32 1,152.14 1,036.69 572.93 432.83 271.32 261.40 Gross Block 2,246.28 2,152.24 2,086.53 1,926.64 1,540.50 1,379.38 859.28 679.21 510.92 449.57 Accumulated Depreciation 762.27 668.33 567.74 477.32 388.36 342.69 286.35 246.38 239.60 188.17 Non Current Assets 1,876.00 1,920.20 1,886.04 1,773.43 1,593.76 1,196.84 973.47 715.27 512.82 426.22 Capital Work in Progress 209.47 152.86 108.19 131.06 261.29 61.33 254.22 198.91 170.20 93.55 Non Current Investment 42.99 42.99 17.89 18.63 28.14 18.26 17.26 17.25 57.16 23.84 Long Term Loans & Adv. 134.68 226.15 230.52 163.96 139.91 66.38 34.93 21.12 8.87 38.68 Other Non Current Assets 4.85 5.88 10.65 10.46 12.28 14.18 9.09 4.27 5.27 8.75 Current Assets 2,543.27 2,057.01 2,026.40 1,554.44 1,169.17 1,095.01 775.07 698.42 573.03 453.65 Current Investments 510.27 121.86 138.99 67.14 64.74 182.38 181.56 76.78 19.46 55.00 Inventories 683.77 635.11 634.22 436.19 414.26 317.37 179.28 189.78 153.05 148.77 Sundry Debtors 977.63 1,043.62 782.30 734.24 423.38 432.19 336.00 350.48 240.85 177.09 Cash & Bank 269.92 145.25 151.98 87.85 35.87 38.67 22.84 21.44 105.69 29.08 Other Current Assets 101.68 29.78 99.10 65.39 230.92 124.40 55.39 59.94 53.98 43.71 Short Term Loans & Adv. 83.12 81.39 219.81 163.63 137.20 12.71 48.26 53.75 42.01 40.33 Net Current Assets 1,635.43 1,587.31 1,320.12 940.14 741.70 794.82 562.83 456.87 328.20 189.69 Total Assets 4,419.27 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85 879.87

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 3,387.99 3,264.34 2,995.63 2,598.87 2,245.21 2,041.37 1,567.69 1,190.86 841.09 593.31 Share Capital 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 17.67 Total Reserves 3,362.38 3,246.87 2,977.70 2,580.86 2,226.57 2,022.05 1,550.00 1,173.17 822.98 575.06 Non-Current Liabilities 177.38 285.02 274.55 227.61 162.23 38.56 8.90 28.63 55.67 80.62 Secured Loans 1.25 1.64 1.60 0.74 0.66 1.01 1.04 5.79 23.31 41.53 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.08 9.94 10.77 Long Term Provisions 146.55 216.04 208.12 155.01 134.15 13.16 4.88 2.59 4.76 2.83 Current Liabilities 1,139.28 647.39 838.82 745.53 498.35 346.05 246.66 259.89 249.59 275.42 Trade Payables 422.77 327.17 373.86 362.34 225.18 249.63 178.18 145.57 109.06 124.54 Other Current Liabilities 669.42 301.47 214.14 180.12 111.45 63.95 46.33 56.72 58.33 47.63 Short Term Borrowings 0.00 0.00 0.00 42.85 33.34 0.00 0.00 46.25 17.90 60.55 Short Term Provisions 47.09 18.75 250.82 160.22 128.38 32.47 22.15 11.35 64.30 42.70 Total Liabilities 4,704.65 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35 949.35 Net Block 1,496.44 1,503.58 1,541.11 1,472.14 1,168.35 1,052.66 589.17 450.74 288.09 279.39 Gross Block 2,282.82 2,206.86 2,140.80 1,976.15 1,578.96 1,417.23 894.94 715.73 549.85 492.00 Accumulated Depreciation 786.38 703.28 599.69 504.01 410.61 364.57 305.77 264.99 261.76 212.61 Non Current Assets 1,870.65 1,932.29 1,891.22 1,790.94 1,605.27 1,202.36 972.65 716.11 512.94 429.30 Capital Work in Progress 209.47 152.86 108.19 131.86 261.61 61.33 254.22 198.91 170.20 93.55 Non Current Investment 25.10 25.10 0.00 12.28 22.87 7.58 0.00 0.00 40.04 8.46 Long Term Loans & Adv. 134.79 236.46 230.74 164.20 148.36 76.79 41.88 21.29 9.34 39.15 Other Non Current Assets 4.85 5.88 11.18 10.46 4.08 4.00 2.34 4.28 5.27 8.75 Current Assets 2,825.18 2,264.46 2,217.78 1,781.07 1,300.52 1,223.62 850.60 763.27 633.41 520.05 Current Investments 510.27 121.86 175.67 67.14 64.74 182.38 181.56 76.78 19.46 55.00 Inventories 815.63 791.07 766.47 495.68 435.71 350.63 211.02 204.58 159.03 155.40 Sundry Debtors 1,056.90 1,019.81 738.43 775.30 459.48 459.79 323.15 372.35 258.76 202.22 Cash & Bank 330.90 211.79 209.61 205.25 100.51 93.09 69.95 43.37 136.76 60.39 Other Current Assets 111.48 34.79 104.15 69.02 240.08 137.73 64.92 66.19 59.40 47.04 Short Term Loans & Adv. 89.39 85.14 223.45 168.68 143.45 23.11 56.29 59.39 47.43 43.66 Net Current Assets 1,685.90 1,617.07 1,378.96 1,035.54 802.17 877.57 603.94 503.38 383.82 244.63 Total Assets 4,695.83 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35 949.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 736.29 542.34 466.99 300.88 311.82 219.17 536.90 276.67 262.92 189.71 PBT 699.85 900.54 902.09 612.67 513.05 562.44 640.65 562.56 444.88 313.06 Adjustment 79.34 55.58 37.07 -36.60 -11.56 0.21 40.16 -21.87 34.18 34.49 Changes in Working Capital 82.66 -220.31 -274.26 -136.66 -86.64 -221.02 -13.32 -111.94 -80.75 -68.15 Cash after chg. in Working capital 861.85 735.81 664.90 439.41 414.85 341.63 667.49 428.75 398.31 279.40 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -125.56 -193.47 -197.91 -138.53 -103.03 -122.46 -130.59 -152.08 -135.39 -89.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -501.31 -66.04 -162.68 -115.91 -136.88 -201.13 -339.66 -139.39 -145.63 -175.57 Net Fixed Assets -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 -120.60 Net Investments -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 -59.98 Others 37.75 52.31 45.45 132.89 116.44 127.90 0.51 75.02 -9.85 5.01 Cash from Financing Activity -105.12 -457.30 -268.90 -134.00 -180.89 -0.54 -198.02 -128.38 -101.18 -19.80 Net Cash Inflow / Outflow 129.86 19.00 35.41 50.97 -5.95 17.50 -0.78 8.90 16.11 -5.66 Opening Cash & Equivalents 139.83 119.88 84.95 30.52 36.22 18.72 19.49 10.59 7.30 12.96 Closing Cash & Equivalent 269.69 138.88 120.36 81.49 30.27 36.22 18.71 19.49 23.41 7.30

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 791.78 561.71 576.31 456.77 374.51 281.12 609.29 326.14 279.42 212.42 PBT 745.25 909.48 900.18 663.97 514.27 622.56 648.17 558.90 456.01 329.85 Adjustment 131.30 91.75 115.27 70.79 61.93 52.48 86.33 53.07 51.21 50.82 Changes in Working Capital 66.52 -200.39 -208.75 -123.16 -83.46 -254.32 25.88 -124.34 -81.69 -74.52 Cash after chg. in Working capital 943.07 800.84 806.70 611.60 492.74 420.72 760.38 487.63 425.53 306.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -151.29 -239.13 -230.39 -154.83 -118.23 -139.60 -151.09 -161.49 -146.11 -93.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -559.60 -74.10 -282.38 -224.40 -222.78 -256.11 -383.12 -209.07 -158.36 -187.80 Net Fixed Assets -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 -120.60 Net Investments -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 -59.98 Others -20.54 44.25 -74.25 24.40 30.54 72.92 -42.95 5.34 -22.58 -7.22 Cash from Financing Activity -107.87 -459.71 -318.29 -128.63 -147.46 -0.20 -201.77 -117.32 -105.19 -20.13 Net Cash Inflow / Outflow 124.31 27.90 -24.36 103.74 4.27 24.81 24.40 -0.25 15.87 4.49 Opening Cash & Equivalents 206.36 177.51 202.35 95.16 90.64 65.83 41.42 41.67 38.62 34.13 Closing Cash & Equivalent 330.67 205.41 177.99 198.90 94.91 90.64 65.82 41.42 54.49 38.62

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 257.83 247.37 222.30 282.03 245.37 219.29 170.89 128.59 89.35 60.94 ROA 13.30% 18.25% 18.66% 14.49% 15.50% 21.16% 31.61% 33.76% 31.17% 28.40% ROE 17.42% 23.78% 25.28% 19.17% 19.25% 24.90% 37.93% 44.01% 46.37% 49.56% ROCE 21.98% 30.05% 34.00% 27.01% 25.21% 32.76% 47.50% 55.13% 59.10% 56.12% Fixed Asset Turnover 1.58 1.50 1.37 1.27 1.21 1.64 2.37 2.64 2.85 2.60 Receivable days 106.35 104.55 100.41 96.19 88.09 76.59 68.73 68.58 55.76 51.00 Inventory Days 69.39 72.68 70.87 70.66 75.32 49.52 36.95 39.76 40.27 47.73 Payable days 138.90 158.98 188.39 57.84 60.10 55.05 50.18 46.47 47.80 61.39 Cash Conversion Cycle 36.84 18.26 -17.11 109.01 103.31 71.06 55.51 61.87 48.23 37.33 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.09 0.24 Interest Cover 134.81 99.74 131.74 68.33 1252.34 2344.50 517.65 135.26 89.80 39.09

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 269.07 254.80 230.83 297.80 257.19 231.78 178.14 135.31 95.57 67.42 ROA 13.21% 17.16% 17.03% 14.44% 14.52% 22.06% 30.69% 31.66% 29.57% 28.05% ROE 17.68% 22.77% 23.38% 19.32% 18.07% 25.98% 36.75% 40.92% 43.24% 47.47% ROCE 22.57% 29.37% 32.20% 27.44% 23.84% 34.49% 45.74% 51.61% 56.43% 54.53% Fixed Asset Turnover 1.69 1.56 1.43 1.46 1.37 1.84 2.49 2.76 2.85 2.61 Receivable days 99.85 94.50 93.66 87.08 81.62 67.06 63.41 65.84 56.64 52.93 Inventory Days 77.25 83.71 78.09 65.68 69.82 48.10 37.89 37.93 38.64 45.48 Payable days 157.44 188.77 260.89 59.55 63.24 57.26 50.30 41.91 46.38 59.31 Cash Conversion Cycle 19.66 -10.56 -89.14 93.21 88.21 57.90 51.01 61.86 48.91 39.10 Total Debt/Equity 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.07 0.09 0.22 Interest Cover 128.61 90.16 109.85 56.75 444.34 1519.41 477.60 115.29 78.03 38.78

Top Investors:

uti flexi cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

tata aia life insurance co ltd-whole life mid cap equity fund-ulif 009 04/01/07 wle 110

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ajanta Pharma - Quarterly Results
31st Oct 2023, 14:15 PM

Read More
Ajanta Pharma gets USFDA’s final nod for Topiramate Extended-Release Capsules
30th Aug 2023, 18:15 PM

The company has received 50 final ANDA approvals, out of which 41 are commercialized
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback